Syra Health (SYRA) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for November 14, 2025, at company headquarters in Carmel, IN.
Proxy materials and 2024 Annual Report are available online, with options for paper or email copies upon request.
Shareholders can vote online, by mail, or in person, with instructions provided for each method.
Voting matters and shareholder proposals
Election of five directors: Priya Prasad, Vijayapal R. Reddy, Ketan Paranjape, Avutu S. Reddy, and Radhika Mereddy.
Ratification of M & K CPAS, PLLC as independent auditor for fiscal year ending December 31, 2025.
Amendment to delete Article IV, Section 4.2.8(D) regarding automatic conversion of Class B Common Stock upon death of a Class B stockholder.
Amendment to allow Class B stockholders to transfer shares to immediate family, heirs, successors, and assigns without conversion.
Board recommends voting "FOR" all proposals.
Board of directors and corporate governance
Board slate includes five nominees for election at the annual meeting.
Board oversight includes recommendations on all proxy proposals.
Latest events from Syra Health
- Population Health revenue up 157% and net loss down 76%, targeting profitability by 2026.SYRA
Q4 202512 Mar 2026 - Q3 2024 revenue up 42%, margins improved, but losses and delisting risk persist.SYRA
Q3 202418 Jan 2026 - 2024 revenue up 45% to $8M, Q4 net loss nearly halved, strong Population Health growth.SYRA
Q4 202419 Dec 2025 - Healthcare firm files $75M shelf registration amid growth plans and financial uncertainty.SYRA
Registration Filing16 Dec 2025 - Healthcare firm targets $75M shelf offering amid growth plans and financial risks.SYRA
Registration Filing16 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and key Class B stock amendments.SYRA
Proxy Filing2 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and Class B stock amendments.SYRA
Proxy Filing2 Dec 2025 - IPO seeks $4.3M for digital health growth amid losses and concentrated insider control.SYRA
Registration Filing29 Nov 2025 - Revenue up 6%, gross margin up, but guidance withdrawn amid federal funding uncertainty.SYRA
Q1 202525 Nov 2025